Gema Navarro-Jiménez, Cristina Fuentes-Santos, Leonor Moreno-Núñez, Jesús Alfayate-García, Carolina Campelo-Gutierrez, Sira Sanz-Márquez, Elia Pérez-Fernández, María Velasco-Arribas, Rafael Hervás-Gómez, Oriol Martín-Segarra, Juan Emilio Losa-García
Objective: To describe the clinical experience with dalbavancin in the treatment of diabetic foot infection in a multidisciplinary unit of a second level hospital.
Methods: A retrospective, descriptive study was made with all patients with diabetic foot infection treated with dalbavancin in the Diabetic Foot Unit of Hospital Universitario Fundación Alcorcón, covering the period from September 2016 to December 2019. Demographic parameters and comorbidities, characteristics of the infection and treatment with dalbavancin were recorded. The cure rate is estimated at 90 days after finishing the treatment … read more